CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
71.65
+1.46 (2.08%)
Jul 21, 2026, 1:36 PM EDT - Market open
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $6.32 billion as of July 21, 2026. Its market cap has increased by 209.94% in one year.
Market Cap
6.32B
Enterprise Value
5.20B
1-Year Change
209.94%
Ranking
Category
Stock Price
$71.65
ChartMarket Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $6.32B, an increase of 423.95%. That is a compound annual growth rate of 94.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 6.32B | 88.69% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 7.13B |
| Cogent Biosciences | 6.75B |
| Erasca | 6.70B |
| PTC Therapeutics | 6.52B |
| Xenon Pharmaceuticals | 6.40B |
| Belite Bio | 6.22B |
| Scholar Rock Holding | 6.12B |
| Ligand Pharmaceuticals | 5.96B |